Skip to content

Clinical trials

Cardiovascular Diseases trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Chile Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20061
20072
20081
20093
20103
20112
20121
20132
20143
20163
20183
20193
20211
20221
20231
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting7
Terminated4
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
GlaxoSmithKline4
Pfizer3
Pontificia Universidad Catolica de Chile3
Takeda3
Novartis Pharmaceuticals2
Sanofi2
United Therapeutics2
University of Chile2
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases40
Hypertension10
Diabetes Mellitus, Type 28
Myocardial Infarction7
Stroke7
Diabetes Mellitus6
Acute Coronary Syndrome5
Atherosclerosis5
Heart Diseases5
Vascular Diseases5

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.